25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Microemulsion-based hydrogel formulation of penciclovir for topical delivery

      , , , , ,
      International Journal of Pharmaceutics
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The purpose of this study was to investigate microemulsion-based hydrogel (MBH) as a topical delivery system for penciclovir. Topical delivery of penciclovir in the forms of microemulsion, MBH and the commercial cream was evaluated in vitro and in vivo. The results of permeation test in vivo in mice showed that compared with the commercial cream, MBH and microemulsion could significantly increase the permeation of penciclovir into both epidermis and dermis. Stability test showed that MBH stored at 4 degrees C for 3 months had no significant change in physicochemical properties. Skin irritation test in rabbit demonstrated that single application or multiple applications of MBH did not cause any erythema or edema, slight skin irritation for microemulsion. Microstructure changes of skins after administration observed under light microscope and scanning electron microscope (SEM) might result from the interaction of the ingredients of microemulsion with skins, which was related with the permeation enhancement of penciclovir. It can be concluded that the MBH could be a promising vehicle for topical delivery of penciclovir.

          Related collections

          Author and article information

          Journal
          International Journal of Pharmaceutics
          International Journal of Pharmaceutics
          Elsevier BV
          03785173
          August 2009
          August 2009
          : 378
          : 1-2
          : 152-158
          Article
          10.1016/j.ijpharm.2009.05.019
          19463929
          35411a13-6bb4-496b-b725-153ccdc88d55
          © 2009

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article